| MLEC | Moolec Science SA | 0.01 | -99.79% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.48% |
| ENVB | Enveric Biosciences Inc | 0.08 | -98.19% |
| CASI | CASI Pharmaceuticals Inc | 0.12 | -97.26% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -96.71% |
| JAGX | Jaguar Health Inc | 0.30 | -93.05% |
| LITS | Lite Strategy Inc | 0.31 | -92.86% |
| AFMD | Affimed N.V. | 0.53 | -87.95% |
| HRTX | Heron Therapeutics Inc | 0.54 | -87.67% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -86.85% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -86.05% |
| FTRE | Fortrea Holdings Inc | 0.63 | -85.73% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -85.29% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -83.54% |
| CELU | Celularity Inc - Class A | 0.85 | -80.60% |
| SRPT | Sarepta Therapeutics Inc | 0.87 | -80.19% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.97 | -77.86% |
| GOSS | Gossamer Bio Inc | 0.98 | -77.72% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -74.47% |
| XLO | Xilio Therapeutics Inc | 1.14 | -74.07% |
| PTN | Palatin Technologies Inc | 1.22 | -72.11% |
| BOLT | Bolt Biotherapeutics Inc | 1.25 | -71.58% |
| FBIOP | Fortress Biotech Inc | 1.25 | -71.52% |
| HCWB | HCW Biologics Inc | 1.25 | -71.49% |
| CRIS | Curis Inc | 1.30 | -70.21% |
| IMRN | Immuron Ltd | 1.34 | -69.44% |
| CSBR | Champions Oncology Inc | 1.36 | -69.05% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -68.16% |
| RVNC | Revance Therapeutics Inc | 1.48 | -66.21% |
| KPTI | Karyopharm Therapeutics Inc | 1.50 | -65.74% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -64.55% |
| MDXG | Mimedx Group Inc | 1.61 | -63.34% |
| SPRO | Spero Therapeutics Inc | 1.61 | -63.27% |
| VNDA | Vanda Pharmaceuticals Inc | 1.61 | -63.13% |
| CRMD | CorMedix Inc | 1.62 | -62.98% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -61.17% |
| AGEN | Agenus Inc | 1.71 | -61.01% |
| MGNX | Macrogenics Inc | 1.74 | -60.37% |
| GLPG | Galapagos NV | 1.74 | -60.28% |
| SVA | Sinovac Biotech Ltd | 1.83 | -58.20% |
| PBYI | Puma Biotechnology Inc | 1.85 | -57.66% |
| NERV | Minerva Neurosciences Inc | 1.87 | -57.36% |
| FBIO | Fortress Biotech Inc | 1.87 | -57.25% |
| THTX | Theratechnologies Inc | 1.98 | -54.73% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -51.79% |
| NAGE | Niagen Bioscience Inc | 2.12 | -51.63% |
| XBIO | Xenetic Biosciences Inc | 2.15 | -50.81% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -49.37% |
| MGX | Metagenomi Inc | 2.23 | -49.21% |
| HRMY | Harmony Biosciences Holdings Inc | 2.25 | -48.71% |
| NVAX | Novavax Inc | 2.32 | -47.00% |
| SPRC | SciSparc Ltd | 2.33 | -46.77% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -44.39% |
| PLX | Protalix BioTherapeutics Inc | 2.44 | -44.37% |
| HYFT | MindWalk Holdings Corp | 2.48 | -43.44% |
| CDXS | Codexis Inc | 2.48 | -43.41% |
| SAVA | Cassava Sciences Inc. | 2.54 | -42.09% |
| RIGL | Rigel Pharmaceuticals | 2.54 | -42.00% |
| PHAR | Pharming Group N.V. | 2.55 | -41.70% |
| CTXR | Citius Pharmaceuticals Inc | 2.60 | -40.58% |
| VRCA | Verrica Pharmaceuticals Inc | 2.62 | -40.29% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | -39.35% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -38.28% |
| REVB | Revelation Biosciences Inc | 2.88 | -34.21% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -32.46% |
| ARDX | Ardelyx Inc | 2.98 | -31.98% |
| CGEN | Compugen Ltd | 2.99 | -31.66% |
| VERU | Veru Inc | 3.11 | -29.01% |
| ATRA | Atara Biotherapeutics Inc | 3.13 | -28.53% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 3.13 | -28.44% |
| EVGN | Evogene Ltd | 3.17 | -27.62% |
| ICCC | Immucell Corp | 3.24 | -25.97% |
| BGMS | Bio Green Med Solution Inc | 3.28 | -25.20% |
| AAPG | Ascentage Pharma Group International | 3.28 | -25.11% |
| MNKD | Mannkind Corp | 3.32 | -24.15% |
| VALN | Valneva SE | 3.35 | -23.58% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.36 | -23.28% |
| JAZZ | Jazz Pharmaceuticals plc | 3.37 | -23.10% |
| EVAX | Evaxion Biotech A/S | 3.38 | -22.87% |
| PTHS | Channel Therapeutics Corporation | 3.41 | -22.09% |
| BMRN | Biomarin Pharmaceutical Inc | 3.50 | -20.20% |
| BCAB | BioAtla Inc | 3.54 | -19.31% |
| SLDB | Solid Biosciences Inc | 3.65 | -16.80% |
| CUE | Cue Biopharma Inc | 3.66 | -16.55% |
| IPSC | Century Therapeutics Inc | 3.72 | -15.15% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -13.28% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.81 | -13.12% |
| INVA | Innoviva Inc | 3.81 | -12.94% |
| CLLS | Cellectis | 3.85 | -12.03% |
| LEGN | Legend Biotech Corp | 3.91 | -10.68% |
| ONCO | Onconetix Inc | 3.92 | -10.41% |
| ACAD | Acadia Pharmaceuticals Inc | 3.98 | -9.04% |
| ADMA | Adma Biologics Inc | 4.03 | -7.96% |
| IMCR | Immunocore Holdings plc | 4.27 | -2.46% |
| INCY | Incyte Corp | 4.28 | -2.28% |
| PHAT | Phathom Pharmaceuticals Inc | 4.30 | -1.82% |
| IVVD | Invivyd Inc | 4.31 | -1.66% |
| STRO | Sutro Biopharma Inc | 4.33 | -1.27% |
| GERN | Geron Corp | 4.51 | +3.04% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | +4.31% |
| GMAB | Genmab | 4.58 | +4.48% |
| BCYC | Bicycle Therapeutics Plc | 4.64 | +5.92% |
| TARS | Tarsus Pharmaceuticals Inc | 4.69 | +7.03% |
| RARE | Ultragenyx Pharmaceutical Inc | 4.71 | +7.47% |
| ABUS | Arbutus Biopharma Corp | 4.76 | +8.59% |
| TLX | Telix Pharmaceuticals Ltd | 4.76 | +8.61% |
| APLM | Apollomics Inc - Class A | 4.77 | +8.79% |
| REGN | Regeneron Pharmaceuticals Inc | 4.77 | +8.91% |
| CHRS | Coherus Biosciences Inc | 4.77 | +8.91% |
| TRAW | Traws Pharma Inc | 4.77 | +8.95% |
| QTTB | Q32 Bio Inc | 4.95 | +13.08% |
| ZLAB | Zai Lab Ltd | 4.96 | +13.33% |
| DTIL | Precision Biosciences Inc | 5.04 | +15.05% |
| ACHV | Achieve Life Sciences Inc | 5.09 | +16.19% |
| VYGR | Voyager Therapeutics Inc | 5.23 | +19.38% |
| ELAB | PMGC Holdings Inc | 5.26 | +20.10% |
| PSTV | Plus Therapeutics Inc | 5.42 | +23.72% |
| CAI | Caris Life Sciences Inc - Class A | 5.44 | +24.18% |
| ENTA | Enanta Pharmaceuticals Inc | 5.51 | +25.77% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.61 | +28.06% |
| ONC | BeiGene Ltd | 5.63 | +28.51% |
| RNA | Atrium Therapeutics Inc | 5.70 | +30.11% |
| EXEL | Exelixis Inc | 5.89 | +34.45% |
| HALO | Halozyme Therapeutics Inc | 5.90 | +34.68% |
| ARVN | Arvinas Inc | 5.98 | +36.50% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | +37.32% |
| GYRE | Gyre Therapeutics Inc | 6.04 | +37.87% |
| SCPH | scPharmaceuticals Inc | 6.10 | +39.14% |
| IOVA | Iovance Biotherapeutics Inc | 6.14 | +40.16% |
| ZVRA | Zevra Therapeutics Inc | 6.26 | +42.89% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.46 | +47.46% |
| KROS | Keros Therapeutics Inc | 6.58 | +50.20% |
| OBIO | Orchestra BioMed Holdings Inc | 6.68 | +52.48% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.89 | +57.28% |
| ANAB | AnaptysBio Inc | 6.90 | +57.50% |
| FDMT | 4D Molecular Therapeutics Inc | 6.92 | +57.96% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | +62.75% |
| TCRX | Tscan Therapeutics Inc | 7.14 | +62.91% |
| RGNX | Regenxbio Inc | 7.23 | +65.04% |
| LENZ | LENZ Therapeutics Inc | 7.45 | +70.06% |
| ASMB | Assembly Biosciences Inc | 7.46 | +70.29% |
| SPRY | ARS Pharmaceuticals Inc | 7.57 | +72.80% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | +72.93% |
| ALGS | Aligos Therapeutics Inc | 7.59 | +73.25% |
| FENC | Fennec Pharmaceuticals Inc | 7.60 | +73.48% |
| PRTA | Prothena Corporation plc | 7.62 | +73.94% |
| NTBL | Notable Labs Inc Ord | 7.65 | +74.62% |
| SEER | Seer Inc - Class A | 7.83 | +78.73% |
| PTCT | PTC Therapeutics Inc | 7.83 | +78.73% |
| VTGN | VistaGen Therapeutics Inc | 7.96 | +81.70% |
| TBPH | Theravance Biopharma Inc | 7.99 | +82.38% |
| CYCN | Cyclerion Therapeutics Inc | 8.06 | +83.98% |
| VCEL | Vericel Corp | 8.06 | +83.98% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | +85.12% |
| IMMP | Immutep Ltd | 8.12 | +85.35% |
| BNTX | BioNTech SE | 8.29 | +89.23% |
| ARQT | Arcutis Biotherapeutics Inc | 8.36 | +90.83% |
| IONS | Ionis Pharmaceuticals Inc | 8.58 | +95.85% |
| ALNY | Alnylam Pharmaceuticals Inc | 8.76 | +99.96% |
| ALEC | Alector Inc | 9.04 | +106.35% |
| GOVX | Geovax Labs Inc | 9.09 | +107.49% |
| TECH | Bio-Techne Corp | 9.17 | +109.32% |
| LPCN | Lipocine Inc | 9.51 | +117.08% |
| NXTC | Nextcure Inc | 9.52 | +117.31% |
| BLRX | Bioline Rx Ltd | 9.56 | +118.22% |
| ACET | Adicet Bio Inc | 9.72 | +121.88% |
| SNGX | Soligenix Inc | 9.78 | +123.24% |
| TVTX | Travere Therapeutics Inc | 9.84 | +124.61% |
| SNDX | Syndax Pharmaceuticals Inc | 9.85 | +124.84% |
| VSTM | Verastem Inc | 9.87 | +125.30% |
| VRTX | Vertex Pharmaceuticals Inc | 9.89 | +125.76% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.04 | +129.18% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | +133.06% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | +137.17% |
| OABI | OmniAb Inc | 10.42 | +137.85% |
| PYXS | Pyxis Oncology Inc | 10.69 | +144.02% |
| MDGL | Madrigal Pharmaceuticals Inc | 10.93 | +149.50% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | +154.52% |
| ARGX | Argen X SE | 11.27 | +157.26% |
| FHTX | Foghorn Therapeutics Inc | 11.34 | +158.85% |
| XNCR | Xencor Inc | 11.41 | +160.45% |
| DYAI | Dyadic International Inc DE | 11.58 | +164.33% |
| PALI | Palisade Bio Inc | 11.78 | +168.90% |
| CCCC | C4 Therapeutics Inc | 11.93 | +172.32% |
| TGTX | TG Therapeutics Inc | 12.00 | +173.92% |
| XBIT | XBiotech Inc | 12.23 | +179.17% |
| CORT | Corcept Therapeutics Inc | 12.63 | +188.30% |
| MDWD | MediWound Ltd | 12.65 | +188.76% |
| ICU | SeaStar Medical Holding Corp | 12.86 | +193.55% |
| MIRM | Mirum Pharmaceuticals Inc | 12.95 | +195.61% |
| SRRK | Scholar Rock Holding Corp | 13.14 | +199.94% |
| RPRX | Royalty Pharma plc - Class A | 13.14 | +199.94% |
| URGN | UroGen Pharma Ltd | 13.37 | +205.19% |
| LXRX | Lexicon Pharmaceuticals Inc | 13.52 | +208.62% |
| ANL | Adlai Nortye Ltd | 13.52 | +208.71% |
| ATHE | Alterity Therapeutics Ltd | 13.60 | +210.44% |
| XCUR | Exicure Inc | 13.61 | +210.67% |
| CRVO | CervoMed Inc | 13.61 | +210.67% |
| SLGL | Sol-Gel Technologies Ltd | 13.67 | +212.04% |
| EDIT | Editas Medicine Inc | 13.68 | +212.27% |
| KURA | Kura Oncology Inc | 13.93 | +217.98% |
| GDTC | CytoMed Therapeutics Ltd | 14.02 | +220.03% |
| COYA | Coya Therapeutics Inc | 14.30 | +226.42% |
| NUVB | Nuvation Bio Inc - Class A | 14.36 | +227.79% |
| MGTX | MeiraGTx Holdings plc | 14.58 | +232.81% |
| XOMA | XOMA Royalty Corp | 14.63 | +233.95% |
| CVAC | CureVac N.V. | 14.83 | +238.52% |
| APLT | Applied Therapeutics Inc | 14.86 | +239.20% |
| RCUS | Arcus Biosciences Inc | 14.93 | +240.80% |
| CRBU | Caribou Biosciences Inc | 15.32 | +249.70% |
| IDYA | Ideaya Biosciences Inc | 15.70 | +258.38% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.28 | +271.62% |
| WVE | Wave Life Sciences Ltd | 16.43 | +275.04% |
| CLGN | CollPlant Biotechnologies Ltd New | 16.50 | +276.64% |
| LGVN | Longeveron Inc - Class A | 16.51 | +276.87% |
| ACOG | Alpha Cognition Inc | 16.80 | +283.49% |
| AXSM | Axsome Therapeutics Inc | 17.09 | +290.11% |
| PLUR | Pluri Inc | 17.50 | +299.47% |
| CANF | Can-Fite Biopharma Ltd | 17.56 | +300.84% |
| BEAM | Beam Therapeutics Inc | 17.79 | +306.09% |
| PRQR | ProQR Therapeutics N.V | 17.90 | +308.60% |
| IMNN | Imunon Inc | 17.94 | +309.51% |
| IPHA | Innate Pharma | 18.77 | +328.46% |
| ASND | Ascendis Pharma A/S | 20.12 | +359.27% |
| NRXS | Neuraxis Inc | 20.19 | +360.87% |
| EQ | Equillium Inc | 20.22 | +361.55% |
| LCTX | Lineage Cell Therapeutics Inc | 20.58 | +369.77% |
| VIVS | VivoSim Labs Inc | 20.99 | +379.13% |
| NTRB | Nutriband Inc | 21.11 | +381.87% |
| SEPN | Septerna Inc | 21.25 | +385.07% |
| PRLD | Prelude Therapeutics Inc | 21.25 | +385.07% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 21.98 | +401.73% |
| ZYME | Zymeworks BC Inc | 22.33 | +409.72% |
| CTMX | CytomX Therapeutics Inc | 22.42 | +411.77% |
| APM | Aptorum Group Limited Class A Ordinary Shares | 23.35 | +433.00% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | +442.13% |
| KALA | Kala Bio Inc | 23.75 | +442.13% |
| IRD | Ocuphire Pharma Inc | 23.98 | +447.38% |
| IGC | IGC Pharma Inc | 24.19 | +452.18% |
| VIR | Vir Biotechnology Inc | 24.75 | +464.96% |
| BRTX | BioRestorative Therapies Inc | 24.97 | +469.98% |
| NBP | NovaBridge Biosciences. | 25.39 | +479.57% |
| KRYS | Krystal Biotech Inc | 25.84 | +489.84% |
| CGEM | Cullinan Oncology Inc | 25.86 | +490.30% |
| ABCL | AbCellera Biologics Inc | 25.99 | +493.26% |
| RNXT | RenovoRx Inc | 26.04 | +494.41% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 26.45 | +503.77% |
| DARE | Dare Bioscience Inc | 26.79 | +511.53% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | +514.04% |
| ABVC | ABVC BioPharma Inc | 27.42 | +525.91% |
| ABEO | Abeona Therapeutics Inc | 27.67 | +531.61% |
| BBIO | BridgeBio Pharma Inc | 27.92 | +537.32% |
| NTLA | Intellia Therapeutics Inc | 28.12 | +541.89% |
| ARMP | Armata Pharmaceuticals Inc | 28.16 | +542.80% |
| INSM | Insmed Inc | 28.42 | +548.73% |
| RANI | Rani Therapeutics Holdings Inc Class A | 29.37 | +570.42% |
| VRDN | Viridian Therapeutics Inc | 29.68 | +577.50% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | +585.71% |
| ADAG | Adagene Inc | 31.61 | +621.55% |
| MESO | Mesoblast Ltd | 33.10 | +655.56% |
| SRZN | Surrozen Inc | 33.76 | +670.63% |
| RYTM | Rhythm Pharmaceuticals Inc | 34.39 | +685.01% |
| IMTX | Immatics N.V | 34.70 | +692.08% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | +694.60% |
| AGIO | Agios Pharmaceuticals Inc | 35.95 | +720.62% |
| CBIO | N/A | 36.36 | +729.98% |
| TOVX | Theriva Biologics Inc | 37.16 | +748.24% |
| CBUS | Cibus Global Ltd. Class A | 39.30 | +797.09% |
| XFOR | X4 Pharmaceuticals Inc | 40.81 | +831.56% |
| OCUL | Ocular Therapeutix Inc | 40.81 | +831.56% |
| NKTR | Nektar Therapeutics | 41.48 | +846.85% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +862.14% |
| HYPD | Eyenovia Inc | 43.89 | +901.86% |
| EVMN | Evommune Inc | 44.84 | +923.55% |
| MCRB | Seres Therapeutics Inc | 45.04 | +928.11% |
| BYSI | BeyondSpring Inc | 45.99 | +949.80% |
| GLUE | Monte Rosa Therapeutics Inc | 46.04 | +950.94% |
| TRDA | Entrada Therapeutics Inc | 47.22 | +977.87% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +995.91% |
| KRRO | Korro Bio Inc | 48.91 | +1016.45% |
| SPRB | Spruce Biosciences Inc | 49.19 | +1022.84% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +1060.28% |
| PPBT | Purple Biotech Ltd | 51.90 | +1084.65% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +1098.40% |
| ALLR | Allarity Therapeutics Inc | 53.04 | +1110.73% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +1119.87% |
| FATE | Fate Therapeutics Inc | 55.18 | +1159.57% |
| CAMP | CAMP4 Therapeutics Corp | 55.57 | +1168.48% |
| VYNE | VYNE Therapeutics Inc | 55.68 | +1170.99% |
| PGEN | Precigen Inc | 57.77 | +1218.70% |
| IBRX | ImmunityBio Inc | 57.87 | +1220.98% |
| STOK | Stoke Therapeutics Inc | 58.07 | +1225.54% |
| COCP | Cocrystal Pharma Inc | 58.22 | +1228.97% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +1237.64% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +1265.95% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +1301.10% |
| NBTX | Nanobiotix | 62.26 | +1321.19% |
| OVID | Ovid Therapeutics Inc | 64.47 | +1371.63% |
| ACIU | AC Immune SA | 65.70 | +1399.71% |
| EPIX | Essa Pharma Inc | 65.79 | +1401.72% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +1422.08% |
| NRIX | Nurix Therapeutics Inc | 67.32 | +1436.69% |
| JANX | Janux Therapeutics Inc | 71.18 | +1524.80% |
| ADXN | Addex Therapeutics Ltd | 71.50 | +1532.11% |
| APRE | Aprea Therapeutics Inc | 73.15 | +1569.77% |
| IVA | Inventiva | 73.66 | +1581.41% |
| LEXX | Lexaria Bioscience Corp | 75.14 | +1615.19% |
| SILO | SILO Pharma Inc | 76.31 | +1641.90% |
| OMER | Omeros Corporation | 76.82 | +1653.54% |
| MAZE | Maze Therapeutics Inc | 81.33 | +1756.49% |
| NRXP | NRX Pharmaceuticals Inc | 83.25 | +1800.32% |
| IMA | Ikena Oncology Inc | 83.32 | +1801.92% |
| TNGX | Tango Therapeutics Inc | 86.42 | +1872.68% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +1875.65% |
| MIST | Milestone Pharmaceuticals Inc | 88.63 | +1923.13% |
| OGEN | Oragenics Inc | 89.28 | +1937.96% |
| ACRS | Aclaris Therapeutics Inc | 89.47 | +1942.30% |
| HUMA | Humacyte Inc | 90.61 | +1968.32% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +1996.86% |
| CVM | Cel-Sci Corp | 92.88 | +2020.14% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +2054.15% |
| RAPP | Rapport Therapeutics Inc | 95.49 | +2079.72% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +2117.84% |
| HIND | ReShape Lifesciences Inc | 104.32 | +2281.28% |
| MREO | Mereo Biopharma Group Plc | 104.68 | +2289.49% |
| CYTK | Cytokinetics Inc | 105.12 | +2299.54% |
| OCGN | Ocugen Inc | 108.42 | +2374.87% |
| RLYB | Rallybio Corp | 109.04 | +2389.02% |
| AIM | AIM ImmunoTech Inc. | 112.05 | +2457.73% |
| MNOV | Medicinova Inc | 113.02 | +2479.87% |
| PTGX | Protagonist Therapeutics Inc | 113.99 | +2502.01% |
| SKYE | Skye Bioscience Inc | 117.90 | +2591.26% |
| UPB | Upstream Bio Inc | 119.09 | +2618.43% |
| GRDX | Entero Therapeutics Inc | 119.29 | +2622.99% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +2627.79% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +2740.32% |
| RNAC | Cartesian Therapeutics Inc | 142.69 | +3157.14% |
| OPT | Opthea Ltd | 151.40 | +3355.87% |
| EYPT | EyePoint Pharmaceuticals Inc | 152.51 | +3381.29% |
| DBVT | DBV Technologies | 153.33 | +3400.01% |
| PRME | Prime Medicine Inc | 156.26 | +3466.89% |
| MOLN | Molecular Partners AG | 156.56 | +3473.74% |
| QURE | uniQure N.V. | 157.78 | +3501.59% |
| NAMS | NewAmsterdam Pharma Company NV | 165.68 | +3681.92% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +3777.79% |
| CRDF | Cardiff Oncology Inc | 175.81 | +3913.15% |
| KYMR | Kymera Therapeutics Inc | 182.36 | +4062.67% |
| GRCE | Acasti Pharma Inc | 197.75 | +4413.97% |
| LSTA | Lisata Therapeutics Inc | 200.88 | +4485.42% |
| GTBP | GT Biopharma Inc | 204.96 | +4578.55% |
| JUNS | Jupiter Neurosciences Inc | 212.82 | +4757.97% |
| SER | AgeX Therapeutics Inc | 224.96 | +5035.08% |
| ASBP | Aspire Biopharma Holdings Inc | 226.40 | +5067.95% |
| TSHA | Taysha Gene Therapies Inc | 238.09 | +5334.80% |
| AZTR | Azitra Inc | 239.97 | +5377.71% |
| GANX | Gain Therapeutics Inc | 255.50 | +5732.21% |
| CMPX | Compass Therapeutics Inc | 269.28 | +6046.76% |
| ATYR | Atyr Pharma Inc | 275.73 | +6193.99% |
| CYBN | Cybin Inc | 278.25 | +6251.52% |
| IBIO | iBio Inc | 279.86 | +6288.27% |
| YDES | YD Bio Ltd | 315.05 | +7091.54% |
| CDIO | Cardio Diagnostics Holdings Inc | 319.80 | +7199.96% |
| ATNM | Actinium Pharmaceuticals Inc | 320.69 | +7220.28% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +7854.40% |
| VRNA | Verona Pharma Plc | 350.73 | +7906.00% |
| AUTL | Autolus Therapeutics plc | 372.63 | +8405.90% |
| ANIX | Anixa Biosciences Inc | 377.78 | +8523.45% |
| RLAY | Relay Therapeutics Inc | 398.28 | +8991.40% |
| TENX | Tenax Therapeutics Inc | 414.72 | +9366.67% |
| CADL | Candel Therapeutics Inc | 436.42 | +9862.01% |
| ALMS | Alumis Inc | 437.16 | +9878.90% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +10817.08% |
| CRNX | Crinetics Pharmaceuticals Inc | 491.45 | +11118.16% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +12198.55% |
| TVRD | Cara Therapeutics Inc | 559.61 | +12674.02% |
| IMRX | Immuneering Corp Class A | 563.62 | +12765.56% |
| ATAI | ATAI Life Sciences N.V. | 565.76 | +12814.41% |
| NGNE | Neoleukin Therapeutics Inc | 583.60 | +13221.64% |
| SLN | Silence Therapeutics Plc | 588.32 | +13329.38% |
| STTK | Shattuck Labs Inc | 608.39 | +13787.51% |
| LNAI | Lunai Bioworks Inc | 645.16 | +14626.85% |
| IMNM | Immunome Inc | 646.50 | +14657.43% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +14742.35% |
| CNTB | Connect Biopharma Holdings Ltd | 656.66 | +14889.35% |
| OTLK | Outlook Therapeutics Inc | 695.79 | +15782.56% |
| OCS | Oculis Holding AG | 705.51 | +16004.43% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +16505.02% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +16613.91% |
| INMB | INmune Bio Inc | 760.34 | +17256.02% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +18002.91% |
| TNYA | Tenaya Therapeutics Inc | 813.22 | +18463.09% |
| SNTI | Senti Biosciences Inc | 852.38 | +19356.98% |
| COGT | Cogent Biosciences Inc | 861.15 | +19557.17% |
| PROK | ProKidney Corp - Class A | 876.39 | +19905.04% |
| ABSI | Absci Corp | 900.52 | +20455.86% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +21657.00% |
| INBX | Inhibrx Biosciences Inc | 1029.47 | +23399.36% |
| CELZ | Creative Medical Technology Holdings Inc | 1195.26 | +27183.79% |
| CRSP | CRISPR Therapeutics AG | 1211.19 | +27547.42% |
| IBO | Impact BioMedical Inc | 1260.68 | +28677.11% |
| CGON | Cg Oncology Inc | 1269.73 | +28883.69% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +29012.43% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +30032.55% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +33205.23% |
| ENTX | Entera Bio Ltd | 1547.08 | +35214.66% |
| TCRT | Alaunos Therapeutics Inc | 1689.15 | +38457.65% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +38987.68% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +42632.87% |
| MBIO | Mustang Bio Inc | 2205.73 | +50249.44% |
| ABVX | Abivax | 2425.97 | +55276.78% |
| PULM | Pulmatrix Inc | 2459.21 | +56035.54% |
| BCDA | BioCardia Inc | 2520.59 | +57436.64% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +63132.80% |
| ROIV | Roivant Sciences Ltd | 3008.13 | +68565.55% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +70019.38% |
| CLDX | Celldex Therapeutics Inc | 3476.34 | +79253.22% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +79282.66% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +80097.80% |
| CMRX | Chimerix Inc | 3613.35 | +82380.68% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +83072.34% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +88725.59% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +91576.87% |
| DNTH | Dianthus Therapeutics Inc | 4088.10 | +93217.65% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +115995.46% |
| IFRX | InflaRx N.V. | 6161.81 | +140553.51% |
| GUTS | Fractyl Health Inc | 7575.74 | +172828.81% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +177590.90% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +193375.93% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +205383.27% |
| RVMD | Revolution Medicines Inc | 9035.10 | +206141.11% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +225318.93% |
| ALT | Altimmune Inc | 10694.01 | +244008.48% |
| LYEL | Lyell Immunopharma Inc | 11272.00 | +257202.06% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +294464.52% |
| GNLX | Genelux Corp | 16310.70 | +372218.73% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +409517.71% |
| DSGN | Design Therapeutics Inc | 29402.82 | +671068.04% |
| TRML | Tourmaline Bio Inc | 30893.12 | +705086.66% |
| TIL | Instil Bio Inc | 54248.82 | +1238219.12% |
| ETNB | 89bio Inc | 111568.68 | +2546639.74% |
| EDSA | Edesa Biotech Inc | 130462.29 | +2977917.74% |
| SVRA | Savara Inc | 145272.62 | +3315988.04% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +10919452.92% |
| NKTX | Nkarta Inc | 1.00M | +22826555.42% |